# BWX Technologies (BWXT) — Financial Analysis

**Exchange:**   
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-12  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/BWXT/thesis · /stocks/BWXT/memo

## Financial Snapshot

---
source: coverage-next-full
ticker: BWXT
step: 04
title: Financial Quality & Adversarial Sweep
date: 2026-06-11
---

### Step 04 — Financial Quality & Adversarial Sweep: BWX Technologies (BWXT)

#### 1. Statement Quality Assessment

##### 1.1 Revenue Quality

BWXT's revenue is recognized primarily under ASC 606 for long-term contracts using the cost-to-cost (percentage of completion) method — standard for defense contractors. This creates the following quality considerations:

| Item | Assessment | Notes |
|------|-----------|-------|
| Revenue recognition method | **High quality** | Cost-to-cost method on long-term gov contracts; widely used and auditor-verified |
| Revenue smoothness | **High** | Long-cycle contracts produce relatively smooth quarterly revenue with some program-delivery lumpiness |
| Deferred revenue risk | **Low** | Government contracts are firm-funded obligations; cancellation risk exists for program cuts but not individual deliveries |
| Non-GAAP gap | **Moderate concern** | GAAP EBITDA $439M vs. non-GAAP ~$574M; $135M gap deserves scrutiny |
| Contract over-billing | **Low risk** | Cost-to-cost method limits aggressive front-loading; DoD audits provide external quality check |

##### 1.2 Earnings Quality

Key adjustments and concerns:

**GAAP vs. Non-GAAP Divergence (~$135M in FY2025):**
- Acquired intangible amortization from Kinectrics (~$60–80M/yr) and A.O.T. are real recurring cash costs only in the sense of the original acquisition price — the amortization is non-cash but the intangibles represent real capital deployed. The company's adjusted EBITDA add-back of these items is standard practice but means non-GAAP earnings meaningfully overstate true underlying economics. [S1][S3]
- Merger/integration costs ($30–50M in FY2025) are arguably one-time but have been recurring as BWXT has been acquisition-active for several years.

**Effective Tax Rate Decline:** ETR fell from 22.6% (FY2021) to 17.2% (FY2025), boosting net income. The decline reflects: R&D tax credits, international tax planning post-Kinectrics. Watch for normalization risk if tax law changes. [S2]

**SG&A Expansion:** SG&A grew from $230M (FY2021) to $394M (FY2025) — a 71% increase against 50% revenue growth. Some of this is Kinectrics overhead, but the ratio still bears watching as a potential efficiency concern. [S2]

##### 1.3 Cash Flow Quality

| Metric | FY2023 | FY2024 | FY2025 |
|--------|--------|--------|--------|
| Net Income ($M) | 246 | 282 | 330 |
| Operating Cash Flow ($M) | 364 | 408 | 480 |
| FCF ($M) | 212 | 255 | 295 |
| CFO/Net Income ratio | 1.48× | 1.45× | 1.46× |
| FCF/Net Income ratio | 0.86× | 0.90× | 0.89× |

CFO consistently exceeds net income by ~45% — this is characteristic of high-quality defense contractors and reflects: non-cash D&A ($109M), favorable working capital characteristics (gov contract advance payments), and modest SBC. FCF/Net income at ~89% is solid, though CapEx has risen ($185M in FY2025 vs $154M in FY2024) as Columbia-class manufacturing capacity investments continue. [S1][S2]

**Q4 FCF Seasonality:** BWXT shows pronounced Q4 FCF concentration: FY2024 Q4 FCF was $224M of $255M annual total; FY2025 Q4 FCF was $57M of $295M annual total (Q4 2025 was weak on absolute basis but Q3 2025 was strong). This quarterly lumpiness is typical of defense contractors with year-end billing/collection patterns. [S2]

##### 1.4 Balance Sheet Quality

| Metric | FY2025 |
|--------|--------|
| Goodwill + Intangibles / Total Assets | ~$(4,272M - 1,233M equity - 503M cash = ~$2,536M debt-like obligations)... | 
| Tangible Book Value Per Share | $4.36 (vs. $13.39 total BV/sh) — $9.03/sh in goodwill/intangibles |
| Goodwill + Intangibles (est.) | ~$830M (derived from BV/TBV gap × ~92M shares) |
| Leverage: Net Debt / Non-GAAP EBITDA | ~$1,513M / $574M = **2.6×** |
| Leverage: Net Debt / GAAP EBITDA | ~$1,513M / $439M = **3.4×** |
| Interest Coverage (EBIT/Interest) | $330M / $44M = **7.5×** — adequate |

The FY2025 balance sheet is materially levered up from the acquisitions. Net debt jumped from $979M (FY2024) to $1,513M (FY2025) due to the $1.25B convertible note issuance funding Kinectrics and A.O.T. This is not inherently problematic given the stable government cash flows, but leverage is above historical comfort levels. Management has guided to FCF of $305–320M in FY2026, which implies rapid deleveraging. [S1][S2]

#### 2. Adversarial Research Sweep

**Note: Transcript analysis not performed (coverage-next-full path). Short reports, investigations, and legal matters sourced from SEC filings, press releases, and web research only.**

##### 2.1 Short Interest and Short Reports

No significant short thesis was identified in available research. BWXT's short interest has historically been modest given the defense-monopoly narrative. Wells Fargo initiated with Underweight in April 2026 at a $200 price target (vs. market ~$183), citing valuation concerns. This represents the current bear thesis: not fundamental impairment but premium multiple risk. [S3]

##### 2.2 Legal and Regulatory Investigations

**DOE/NNSA contract compliance:** As a contractor at nuclear weapons facilities, BWXT is subject to ongoing performance reviews and potential contractual disputes. The 10-K discloses the standard DOE contractor risk language. No material legal proceedings were identified beyond ordinary course M&O operational matters. [S1]

**Nuclear safety incidents:** No significant radiological incidents or NRC enforcement actions were identified for BWXT's facilities. The company's safety record is integral to its sole-source status — a safety failure would be the most material adverse event possible for the business. [S1]

**Environmental liabilities:** BWXT has legacy environmental liabilities from historical nuclear operations (pre-Babcock & Wilcox spinoff). These are disclosed in the 10-K and are managed under DOE indemnification in many cases. Estimated immaterial impact on a go-forward basis. [S1]

**Securities litigation:** No material class action or SEC investigation identified. [S1]

##### 2.3 Accounting Concerns

| Concern | Severity | Notes |
|---------|----------|-------|
| GAAP/Non-GAAP gap of ~$135M | **Moderate** | Analysts should use non-GAAP cautiously; real underlying economics closer to GAAP EBITDA on ongoing basis |
| Convertible note accounting | **Low** | $1.25B zero-coupon convertible note; treated as debt; no material accounting ambiguity |
| Kinectrics goodwill | **Low-Moderate** | ~$400M+ in Kinectrics goodwill likely on balance sheet; impairment risk if Kinectrics underperforms vs. acquisition case |
| Pension obligations | **Moderate** | Defense contractors typically carry legacy pension liabilities; BWXT has defined-benefit plans from legacy Babcock & Wilcox obligations — worth monitoring in periods of rising discount rates |

##### 2.4 Acquisition Risk Overlay

The two FY2025 acquisitions (A.O.T. + Kinectrics) represent material integration risk:
- **A.O.T.** (January 2025): Classified defense manufacturing; limited public disclosure. Size appears smaller (~$100M revenue range based on context). Integration risk: cultural alignment with classified defense work.
- **Kinectrics** (May 2025): Canada/UK/Australia industrial nuclear testing; ~$231M revenue. This is BWXT's largest commercial acquisition. Integration risk: geographic expansion across 3 countries, different union/labor structures in Canada, mixed nuclear/non-nuclear revenue base. [S1][S3]

#### 3. Financial Quality Score

| Dimension | Score (1-5) | Notes |
|-----------|-------------|-------|
| Revenue recognition quality | 4 | Standard cost-to-cost; conservative |
| Earnings quality (GAAP) | 3 | GAAP/non-GAAP gap is meaningful; tax rate tailwind reversible |
| Cash flow quality | 5 | CFO consistently exceeds net income; high visibility |
| Balance sheet health | 3 | Levered up post-acquisitions; but stable FCF to deleverage |
| Accounting transparency | 4 | Standard defense-contractor disclosures; no red flags |
| **Overall** | **3.8/5** | High-quality business with temporary leverage from acquisitions |

#### 4. Source Index

| ID | Source | Type | Retrieved |
|----|--------|------|-----------|
| [S1] | SEC 10-K FY2025 (financial statements + risk factors) | Primary filings | 2026-06-11 |
| [S2] | StockAnalysis.com — income statement, balance sheet, cash flow | Financial database | 2026-06-11 |
| [S3] | Consensus data; company guidance; press releases | Consensus/guidance | 2026-06-11 |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/BWXT/fundamental

## Navigation

- Overview: /stocks/BWXT
- Financials (this page): /stocks/BWXT/financials
- Thesis: /stocks/BWXT/thesis
- Investment Memo: /stocks/BWXT/memo
- Coverage universe: /stocks